| Literature DB >> 18723724 |
F S Y Fan1, K M Chow, C C Szeto, P K T Li.
Abstract
Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18723724 DOI： 10.1136/emj.2008.059923
Source DB: PubMed Journal: Emerg Med J ISSN： 1472-0205 Impact factor: 2.740